Accueil / Tag Archives: General Health

Tag Archives: General Health

Ligand to Participate in Two Upcoming Investor Conferences

Monday, May 22nd 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: 14th Annual Craig-Hallum Institutional Investor Conference in Minneapolis. Conference takes place on Wednesday, May 31, 2017 with one-on-one meetings only. John …

Plus »

Sunovion Announces Utibron™ Neohaler® (indacaterol/glycopyrrolate) Inhalation Powder Data Showing Lung Function and Health-Related Quality of Life Improvement in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Tuesday, May 23rd 2017 at 1:18pm UTC – Presentations at the American Thoracic Society 2017 International Conference (ATS 2017) also included long-term safety data and pooled analyses of pivotal studies – MARLBOROUGH, Mass.–(BUSINESS WIRE)– Sunovion Pharmaceuticals Inc. (Sunovion) announced that multiple data analyses from two Phase 3 studies demonstrating that …

Plus »

FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications

Thursday, May 25th 2017 at 5:16pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval of the Company’s proposed epoetin alfa biosimilar across all indications. This marks the first time a biosimilar erythropoiesis-stimulating agent …

Plus »

BIO Applauds Creation of FDA Opioid Policy Steering Committee

Wednesday, May 24th 2017 at 1:28pm UTC WASHINGTON–(BUSINESS WIRE)– Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug Administration (FDA): “We commend Commissioner Gottlieb for his leadership in establishing the Opioid …

Plus »

Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States

Wednesday, May 24th 2017 at 10:00am UTC AllerVarx Sales Currently Expected to Contribute at Least $1 Million in Annual Revenue SAN DIEGO–(BUSINESS WIRE)– Innovus Pharmaceuticals, Inc. (« Innovus Pharma » or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer …

Plus »

bluebird bio Announces Collaboration with Duke University’s Robert J. Margolis, MD, Center for Health Policy on Value-Based Payment Framework for Gene Therapy

Tuesday, May 23rd 2017 at 12:00pm UTC – Collaboration includes industry leaders; aims to develop strategies for sustainable, value-based approach to access transformative gene therapy treatments – CAMBRIDGE, Mass.–(BUSINESS WIRE)– bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and …

Plus »

GlycoMimetics Announces Pricing of Public Offering of Common Stock

Wednesday, May 24th 2017 at 12:00pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a price to the …

Plus »

Carestream Health Receives New Innovative Technology Contract From Vizient, Inc., for Its OnSight 3D Extremity Imaging System

Tuesday, May 23rd 2017 at 12:30pm UTC ROCHESTER, N.Y.–(BUSINESS WIRE)– Carestream Health announced it has received an Innovative Technology contract from Vizient, Inc., for its CARESTREAM OnSight 3D Extremity System. Vizient is the largest member-driven health care performance improvement company in the country. The contract was based on a recommendation …

Plus »

EpicGenetics Expands to Canada with First Definitive Diagnostic Blood Test for Fibromyalgia

Thursday, May 25th 2017 at 12:00pm UTC — Canadians to Access FM/a® Test for Fibromyalgia, Receive an Accurate Diagnosis and Participate in Global Genetic Study to Uncover the Disease’s Origins — LOS ANGELES–(BUSINESS WIRE)– EpicGenetics, a privately held biomedical company dedicated to improving the diagnosis and treatment of fibromyalgia, today …

Plus »

Global Bone Graft and Substitute Market (2017-2023) – Segmented by Type, Application & Region – Research and Markets

Wednesday, May 24th 2017 at 1:18pm UTC DUBLIN–(BUSINESS WIRE)– Research and Markets has announced the addition of the « Global Bone Graft and Substitute Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023 » report to their offering. The global bone graft and substitutes market is anticipated to grow at …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...